HWLAX
Price
$46.70
Change
+$0.49 (+1.06%)
Updated
Oct 3 closing price
Net Assets
371.54M
VVIAX
Price
$73.15
Change
+$0.38 (+0.52%)
Updated
Oct 3 closing price
Net Assets
202.84B
Interact to see
Advertisement

HWLAX vs VVIAX

Header iconHWLAX vs VVIAX Comparison
Open Charts HWLAX vs VVIAXBanner chart's image
Hotchkis & Wiley Large Cap Fdml Value A
Price$46.70
Change+$0.49 (+1.06%)
VolumeN/A
Net Assets371.54M
Vanguard Value Index Adm
Price$73.15
Change+$0.38 (+0.52%)
VolumeN/A
Net Assets202.84B
HWLAX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
HWLAX vs. VVIAX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HWLAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. HWLAX (372M). VVIAX pays higher dividends than HWLAX: VVIAX (2.08) vs HWLAX (1.18). HWLAX was incepted earlier than VVIAX: HWLAX (24 years) vs VVIAX (25 years). HWLAX (1.20) is less costly to investors than VVIAX (0.05). HWLAX is a more actively managed with annual turnover of: 22.00 vs. VVIAX (9.00). HWLAX has a lower initial minimum investment than VVIAX: HWLAX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 8.34 vs. HWLAX (4.35). HWLAX (80.13) and VVIAX (79.65) have equivalent 5 years return.
HWLAXVVIAXHWLAX / VVIAX
Total Expense Ratio1.200.052,400%
Annual Report Gross Expense Ratio1.200.052,400%
Fund Existence24 years25 years-
Gain YTD13.84710.852128%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets372M203B0%
Annual Yield % from dividends1.182.0857%
Returns for 1 year4.358.3452%
Returns for 3 years23.9144.0454%
Returns for 5 years80.1379.65101%
Returns for 10 years104.15137.1376%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATYR0.780.07
+9.20%
aTyr Pharma Inc
TRC16.190.41
+2.60%
Tejon Ranch Co
BZ23.470.07
+0.30%
Kanzhun Limited
GTBP0.64N/A
-0.05%
GT Biopharma
DXPE126.97-0.66
-0.52%
DXP Enterprises